CClinicalTrials.gg
CompletedNCT02177877Updated Jul 14, 2021

A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary

An observational study in Epilepsy, sponsored by Stanford University. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2021-07-14.

Sponsored by Stanford University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
30
Ages
18 Years to 90 Years
Sex
All
01

Study summary

This study will assess whether a movement detecting wristwatch can accurately detect seizures and seizure characteristics and record them into an online epilepsy diary. The patients may manually record a description into the online epilepsy diary of the symptoms they experienced before, during or after the seizure.

Read the detailed description

Typically, health care providers receive inaccurate patient self- reports. This pilot trial will document the feasibility of accurately recording and logging seizures into a cloud-based diary, under circumstances of controlled video-EEG monitoring to serve as a comparison "gold standard." More explicitly, we are testing the efficacy of the wristwatch in capturing movement parameters correlated with seizure activity and whether these parameters can be accurately uploaded into an online epilepsy diary. In the future, biosensor data could be valuable to more precisely obtain seizure data for clinical decision making as well as use in clinical trials.

02

Conditions studied

  • Epilepsy

Keywords

  • Epilepsy
  • Seizures
  • Wrist accelerometer
  • Epilepsy diary
  • Seizure detection
  • Biosensor
03

In context

Epilepsy

1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.

This study's enrollment of 30 is below the median of 102 across 521 observational studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with epilepsy over the age of 18 enrolled at the Stanford Epilepsy Monitoring Unit.

Inclusion criteria

-Adults over the age of 18 with known epileptic convulsive seizures already being admitted to the EMU for continuous video EEG.

Exclusion criteria

Exclusion Criteria:

  • Patients with only non-convulsive events or only psychogenic non-epileptic seizures.
  • Patients who are unable to provide consent.
  • Patients who have developmental delay.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Capture rate of convulsive seizure events by the watch and watch-diary interface compared to video electroencephalography (vEEG)

    Time frame: up to 7 days

Secondary outcomes

  1. Capture rate of non-seizure events by the watch and watch-diary interface compared to vEEG

    Time frame: up to 7 days

  2. Frequency of movements of the watch diary interface vs vEEG

    Time frame: up to 7 days

  3. Amplitude of movements of the watch diary interface vs vEEG

    Time frame: up to 7 days

  4. Seizure semiology captured by the watch vs vEEG.

    Time frame: up to 7 days.

  5. Specificity of audio recordings of the watch vs vEEG

    Will record audio through the watch and vEEG to assess the specificity of this parameter for epileptic vs nonepileptic seizures

    Time frame: up to 7 days

Other outcomes

  1. Recording accuracy of convulsive seizure events by the watch and watch-diary interface compared to vEEG

    Will measure the date and time, duration and shake intensity of convulsive seizure events by the watch and watch-diary interface compared to vEEG

    Time frame: up to 7 days

  2. Feasibility of use of device

    Will survey whether the device was easy, neutral, difficult to use

    Time frame: up to 7 days

  3. Recording accuracy of partial seizures

    Will compare partial seizure events detected by vEEG vs. watch-diary vs. patient log vs. caregiver log

    Time frame: up to 7 days

07

Study locations

1 site
  • Stanford Hospital and Clinics
    Stanford, California 94305, United States
08

References and documents

Publications

  • Velez M, Fisher RS, Bartlett V, Le S. Tracking generalized tonic-clonic seizures with a wrist accelerometer linked to an online database. Seizure. 2016 Jul;39:13-18. doi: 10.1016/j.seizure.2016.04.009. Epub 2016 Apr 29. PubMed 27205871 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02177877
Lead sponsor
Stanford University
Collaborators
SmartMonitor
Responsible party
Scheherazade Le (Principle Investigator, Stanford University) — Principal investigator
First posted
Jun 30, 2014
Start date
Jun 2014
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Jul 14, 2021

Study contacts

Scheherazade Le, MD
principal investigator · Stanford University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion